Medtronic has backed CoreMap to address a critical unmet need in atrial fibrillation treatment.
Medtronic leads $37M investment in ablation mapping startup CoreMap
Medtronic leads $37M investment in ablation mapping startup CoreMap is a pharma and life sciences industry update from MedTech Dive. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Source: MedTech Dive